The biomarkers used in our multimarker panels (MR‐proADM, CRP, D‐dimer, and LDH) are not variant‐specific, but instead reflect host pathophysiological responses such as systemic inflammation, endothelial dysfunction, and coagulation abnormalities. The gene discussed is CRP; the disease is endothelial dysfunction.